Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Price:
50.91
CNY
-0.86%
Market Closed
Market Cap:
11.9B
CNY
Balance Sheet
Balance Sheet Decomposition
Shanghai Haohai Biological Technology Co Ltd
Shanghai Haohai Biological Technology Co Ltd
| Current Assets | 3.7B |
| Cash & Short-Term Investments | 2.7B |
| Receivables | 386.6m |
| Other Current Assets | 546.4m |
| Non-Current Assets | 3.5B |
| Long-Term Investments | 501m |
| PP&E | 1.8B |
| Intangibles | 1.1B |
| Other Non-Current Assets | 73.5m |
Balance Sheet
Shanghai Haohai Biological Technology Co Ltd
Shanghai Haohai Biological Technology Co Ltd
Currency: CNY
Millions
Annual
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
2 010
|
1 797
|
1 443
|
3 223
|
3 093
|
2 901
|
2 542
|
2 740
|
2 629
|
|
| Cash |
0
|
0
|
1
|
1
|
1
|
0
|
559
|
2 740
|
2 629
|
|
| Cash Equivalents |
2 010
|
1 797
|
1 442
|
3 222
|
3 092
|
2 900
|
1 983
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
8
|
22
|
11
|
7
|
20
|
96
|
|
| Total Receivables |
338
|
391
|
492
|
392
|
345
|
390
|
428
|
398
|
387
|
|
| Accounts Receivables |
235
|
330
|
385
|
382
|
334
|
371
|
382
|
328
|
316
|
|
| Other Receivables |
103
|
61
|
108
|
10
|
12
|
19
|
46
|
70
|
70
|
|
| Inventory |
118
|
175
|
198
|
240
|
255
|
355
|
485
|
526
|
491
|
|
| Other Current Assets |
21
|
22
|
160
|
82
|
95
|
56
|
71
|
66
|
56
|
|
| Total Current Assets |
2 487
|
2 385
|
2 293
|
3 945
|
3 810
|
3 713
|
3 532
|
3 750
|
3 658
|
|
| PP&E Net |
463
|
637
|
726
|
939
|
1 037
|
1 241
|
1 401
|
1 548
|
1 761
|
|
| PP&E Gross |
463
|
637
|
726
|
939
|
1 037
|
1 241
|
1 401
|
1 548
|
1 761
|
|
| Accumulated Depreciation |
122
|
149
|
187
|
249
|
327
|
431
|
532
|
637
|
727
|
|
| Intangible Assets |
327
|
491
|
468
|
614
|
579
|
783
|
784
|
729
|
705
|
|
| Goodwill |
292
|
332
|
332
|
334
|
386
|
407
|
411
|
413
|
423
|
|
| Long-Term Investments |
64
|
186
|
592
|
298
|
456
|
723
|
671
|
607
|
501
|
|
| Other Long-Term Assets |
59
|
78
|
26
|
23
|
32
|
84
|
93
|
59
|
74
|
|
| Other Assets |
292
|
332
|
332
|
334
|
386
|
407
|
411
|
413
|
423
|
|
| Total Assets |
3 693
N/A
|
4 109
+11%
|
4 436
+8%
|
6 152
+39%
|
6 299
+2%
|
6 950
+10%
|
6 892
-1%
|
7 105
+3%
|
7 121
+0%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
20
|
39
|
37
|
37
|
28
|
46
|
55
|
55
|
62
|
|
| Accrued Liabilities |
63
|
60
|
70
|
72
|
68
|
94
|
224
|
197
|
194
|
|
| Short-Term Debt |
27
|
19
|
23
|
5
|
79
|
49
|
5
|
10
|
212
|
|
| Current Portion of Long-Term Debt |
32
|
61
|
94
|
20
|
9
|
17
|
29
|
207
|
94
|
|
| Other Current Liabilities |
394
|
299
|
228
|
226
|
250
|
281
|
198
|
248
|
304
|
|
| Total Current Liabilities |
536
|
478
|
451
|
360
|
434
|
487
|
511
|
716
|
866
|
|
| Long-Term Debt |
0
|
18
|
16
|
24
|
20
|
39
|
84
|
191
|
143
|
|
| Deferred Income Tax |
84
|
126
|
127
|
111
|
102
|
158
|
164
|
162
|
152
|
|
| Minority Interest |
82
|
185
|
224
|
199
|
244
|
347
|
388
|
367
|
342
|
|
| Other Liabilities |
88
|
102
|
6
|
4
|
8
|
205
|
231
|
19
|
44
|
|
| Total Liabilities |
789
N/A
|
909
+15%
|
825
-9%
|
697
-15%
|
808
+16%
|
1 237
+53%
|
1 378
+11%
|
1 455
+6%
|
1 546
+6%
|
|
| Equity | ||||||||||
| Common Stock |
160
|
160
|
160
|
178
|
177
|
176
|
174
|
171
|
233
|
|
| Retained Earnings |
973
|
1 259
|
1 638
|
1 936
|
2 046
|
2 399
|
2 458
|
2 818
|
2 981
|
|
| Additional Paid In Capital |
1 770
|
1 770
|
1 770
|
3 282
|
3 260
|
3 091
|
3 003
|
2 981
|
2 775
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
104
|
226
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
28
|
0
|
74
|
248
|
228
|
|
| Other Equity |
1
|
12
|
43
|
60
|
36
|
48
|
47
|
32
|
40
|
|
| Total Equity |
2 904
N/A
|
3 201
+10%
|
3 612
+13%
|
5 455
+51%
|
5 491
+1%
|
5 713
+4%
|
5 515
-3%
|
5 650
+2%
|
5 575
-1%
|
|
| Total Liabilities & Equity |
3 693
N/A
|
4 109
+11%
|
4 436
+8%
|
6 152
+39%
|
6 299
+2%
|
6 950
+10%
|
6 892
-1%
|
7 105
+3%
|
7 121
+0%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
160
|
160
|
160
|
178
|
177
|
246
|
244
|
234
|
230
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
